--- title: "Brii Biosciences (2137) stock: news and investor profile" url: "https://aibio.space/companies/brii-biosciences/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Brii Biosciences Limited (HKEX: 2137), China. The directory classifies it as Biotechnology. Listing facts, related biotech companies and news on aibio.space." --- 2137 Brii Biosciences Limited HKEX · China # Brii Biosciences (2137) news Brii Biosciences Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 2137, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Brii Biosciences news We have not published a story on Brii Biosciences yet. When there is news, it will appear here. ## Brii Biosciences at a glance - **Ticker**: 2137 - **Listing**: HKEX - **Country**: China ### Related companies - [TransThera Sciences (Nanjing).](https://aibio.space/companies/transthera-sciences-nanjing/) HKEX: 2617 - [Sichuan Kelun Pharmaceutical Co.](https://aibio.space/companies/sichuan-kelun-pharmaceutical/) SZSE: 002422 - [Zhejiang Laifual Drive Co.](https://aibio.space/companies/zhejiang-laifual-drive/) HKEX: 3952 - [JW (Cayman) Therapeutics Co.](https://aibio.space/companies/jw-cayman-therapeutics/) HKEX: 2126 - [XtalPi Holdings](https://aibio.space/companies/xtalpi/) HKEX: 2228 - [Hebei Changshan Biochemical Pharmaceutical Co.](https://aibio.space/companies/hebei-changshan-biochemical-pharmaceutical/) SZSE: 300255 - [Hualan Biological Engineering](https://aibio.space/companies/hualan-biological-engineering/) SZSE: 002007 - [Boji Medical Technology Co.](https://aibio.space/companies/boji-medical-technology/) SZSE: 300404 ### Also on HKEX - [China Medical System Holdings](https://aibio.space/companies/china-medical-system/) 867 - [PuraPharm Corp.](https://aibio.space/companies/purapharm/) 1498 - [Qyuns Therapeutics Co.](https://aibio.space/companies/qyuns-therapeutics/) 2509 - [JBM (Healthcare)](https://aibio.space/companies/jbm-healthcare/) 2161 - [Pak Fah Yeow International](https://aibio.space/companies/pak-fah-yeow-international/) 239 - [Cutia Therapeutics](https://aibio.space/companies/cutia-therapeutics/) 2487 ## Questions about Brii Biosciences What is the ticker symbol of Brii Biosciences? Brii Biosciences Limited trades under the ticker 2137 on HKEX. Where is Brii Biosciences listed? Brii Biosciences Limited is listed on HKEX. Our directory also records these other listings: GETTEX:7SS. Which country or territory is Brii Biosciences listed under? Our directory records Brii Biosciences Limited under China. What does Brii Biosciences do? Our directory classifies Brii Biosciences Limited as: Biotechnology. This is a directory classification, not a description of the pipeline. What is the ISIN of Brii Biosciences? The ISIN recorded for Brii Biosciences Limited is KYG1645A1094. Does aibio.space cover Brii Biosciences? aibio.space lists Brii Biosciences Limited among 2,820 public biotech companies and publishes its news here as stories appear. Which companies are similar to Brii Biosciences? Companies in our directory listed in the same country and business area as Brii Biosciences: TransThera Sciences (Nanjing)., Sichuan Kelun Pharmaceutical Co., Zhejiang Laifual Drive Co., JW (Cayman) Therapeutics Co., XtalPi Holdings, Hebei Changshan Biochemical Pharmaceutical Co.. ## Investor discussion: Brii Biosciences Members talk about Brii Biosciences (2137). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Brii Biosciences, newest first. Each line links the filing it comes from. 1. 2026-05-22 Legal Legal proceedings: INSIDE INFORMATION IN RELATION TO ARBITRATION PROCEEDINGS. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0522/2026052200776.pdf) 2. 2026-04-23 Financings Share or debt issue: (1) PROPOSALS FOR ADOPTION OF THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS; (2) RE-ELECTION OF RETIRING DIRECTORS; (3) RE-APPOINTMENT OF AUDITOR; (4) GENERAL MANDATES TO ISSUE AND BUY-BACK SHARES; AND (5) NOTICE OF ANNUAL GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0423/2026042300742.pdf) 3. 2026-04-16 Legal Legal proceedings: INSIDE INFORMATION IN RELATION TO ARBITRATION PROCEEDINGS. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0416/2026041601025.pdf) 4. 2025-04-25 Financings Share or debt issue: (1) PROPOSALS FOR ADOPTION OF THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS; (2) RE-ELECTION OF RETIRING DIRECTORS; (3) RE-APPOINTMENT OF AUDITOR; (4) GENERAL MANDATES TO ISSUE AND BUY-BACK SHARES; AND (5) NOTICE OF ANNUAL GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0425/2025042503491.pdf) 5. 2025-01-10 Mergers Transaction under the Listing Rules: SUPPLEMENTAL ANNOUNCEMENT DISCLOSEABLE TRANSACTION IN RELATION TO NOMINEE DESIGNATION AGREEMENT. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0110/2025011000991.pdf) 6. 2024-12-31 Mergers Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION IN RELATION TO NOMINEE DESIGNATION AGREEMENT. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2024/1231/2024123101810.pdf) ## Press releases Headlines of Brii Biosciences's own announcements, newest first. Each opens the full release on the newswire that carried it. 1. 2026-10-15 HKEXnews [VOLUNTARY ANNOUNCEMENT Launch of BRiSC, an siRNA Therapeutics Discovery Platform](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1015/2026101501064.pdf) 2. 2026-10-08 HKEXnews [GRANT OF SHARE OPTIONS AND RESTRICTED SHARE UNITS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1008/2026100801375.pdf) 3. 2026-09-17 HKEXnews [Notification Letter and Request Form for Non-registered Shareholders](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0917/2026091700558.pdf) 4. 2026-09-17 HKEXnews [Notification Letter and Change Request Form for Registered Shareholders](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0917/2026091700522.pdf) 5. 2026-08-20 HKEXnews [INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0821/2026082100041.pdf) 6. 2026-07-02 HKEXnews [INSIDE INFORMATION Announces Topline End-of-Treatment Data from Phase 2b ENRICH and ENHANCE Studies for the Treatment of Chronic Hepatitis B](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0703/2026070300087.pdf) 7. 2026-06-17 HKEXnews [VOLUNTARY ANNOUNCEMENT SHARE BUY-BACK PROGRAMME](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0617/2026061701774.pdf) 8. 2026-06-16 HKEXnews [POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 16, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0616/2026061601282.pdf) 9. 2026-05-22 HKEXnews [INSIDE INFORMATION IN RELATION TO ARBITRATION PROCEEDINGS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0522/2026052200776.pdf) 10. 2026-04-26 HKEXnews [VOLUNTARY ANNOUNCEMENT Presents Cross-Study Analysis of Post-Treatment HBsAg Rebound at APASL 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0426/2026042600129.pdf) 11. 2026-04-23 HKEXnews [NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0423/2026042300762.pdf) 12. 2026-04-23 HKEXnews [(1) PROPOSALS FOR ADOPTION OF THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS; (2) RE-ELECTION OF RETIRING DIRECTORS; (3) RE-APPOINTMENT OF AUDITOR; (4) GENERAL MANDATES TO ISSUE AND BUY-BACK SHARES; AND (5) NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0423/2026042300742.pdf) 13. 2026-04-16 HKEXnews [INSIDE INFORMATION IN RELATION TO ARBITRATION PROCEEDINGS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0416/2026041601025.pdf) 14. 2026-03-19 HKEXnews [Notification of 2025 PFIC status](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0319/2026031901073.pdf) 15. 2026-03-19 HKEXnews [ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0319/2026031901056.pdf) 16. 2025-11-16 HKEXnews [TERMS OF REFERENCE OF THE NOMINATION COMMITTEE](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1116/2025111600015.pdf) 17. 2025-11-10 HKEXnews [VOLUNTARY ANNOUNCEMENT Presents Late-Breaking Data from Ongoing Phase 2 ENSURE Study at AASLD 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1110/2025111001193.pdf) 18. 2025-11-07 HKEXnews [VOLUNTARY ANNOUNCEMENT Publication of Phase 2 ENSURE Study Results in Nature Medicine](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1107/2025110701554.pdf) 19. 2025-10-31 HKEXnews [GRANT OF SHARE OPTIONS](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1031/2025103102082.pdf) 20. 2025-08-27 HKEXnews [SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE ANNUAL REPORT FOR THE YEAR ENDED DECEMBER 31, 2024](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0827/2025082700826.pdf) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:2137 on TradingView](https://www.tradingview.com/symbols/HKEX-2137/). ## Listing details Brii Biosciences Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 2137, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Brii Biosciences Limited - **Ticker**: 2137 - **Listing**: HKEX - **Country or territory**: China - **Business scope**: Biotechnology - **ISIN**: KYG1645A1094 - **Other listed symbols**: GETTEX:7SS - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-2137/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/brii-biosciences/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Brii Biosciences (2137) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/brii-biosciences/